MedPath

Improvement of stage 1 hypertension by transcutaneous acupoint electrical stimulation based on mobile health: a randomized controlled pilot trial

Phase 1
Recruiting
Conditions
Stage 1 Hypertension
Registration Number
ITMCTR1900002511
Lead Sponsor
Beijing University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Meet the diagnostic criteria for stage 1 hypertension;
2. Age between 35 and 65 years old;
3. No language and mental retardation, can successfully answer and fill out the questionnaire;
4. Voluntary signing of informed consent.

Exclusion Criteria

1. Contraindications for the use of acupoint stimulators: wearing a pacemaker and other implanted medical devices; suffering from acute diseases, infectious diseases, malignant tumors;cardiovascular disease, cerebrovascular disease, liver and kidney dysfunction or other malignant diseases; scars, bruises, scratches or inflammation on the skin of the acupuncture points.
2. Hypertension caused by other vascular diseases, primary aldosteronism, other endocrine hypertension, and secondary hypertension caused by other causes.
3. Receiving drugs that affect blood pressure except antihypertensive drugs in previous 2 months such as glucocorticoids, central nervous system inhibitors.
4. Uncontrolled diabetes.
5. Receiving acupuncture treatment in previous 1 month.
6. Drug or alcohol abuse.
7. Pregnant women or women in lactation period.
8. Joined any other study in process.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath